Menu
Search
|

Menu

Close
X

Chugai Pharmaceutical Co Ltd 4519.T (Tokyo Stock Exchange)

5,980.00 JPY
-20.00 (-0.33%)
As of 7:00 AM BST
chart
Previous Close 6,000.00
Open 6,020.00
Volume 783,400
3m Avg Volume 820,349
Today’s High 6,080.00
Today’s Low 5,970.00
52 Week High 6,210.00
52 Week Low 4,065.00
Shares Outstanding (mil) 559.69
Market Capitalization (mil) 2,650,113.00
Forward P/E 44.56
Dividend (Yield %) 29.00 ( 1.16 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.38 Mean rating from 13 analysts

KEY STATS

Revenue (mm, JPY)
FY18
147,427
FY17
534,198
FY16
491,781
FY15
498,840
EPS (JPY)
FY18
50.914
FY17
132.828
FY16
97.975
FY15
111.787
*Note: Units in Millions of Yen
**Note: Units in Yen

KEY RATIOS

Price to Earnings (TTM)
vs sector
44.56
32.74
Price to Sales (TTM)
vs sector
5.33
5.71
Price to Book (MRQ)
vs sector
3.88
5.37
Price to Cash Flow (TTM)
vs sector
--
23.32
Total Debt to Equity (MRQ)
vs sector
0.06
16.46
LT Debt to Equity (MRQ)
vs sector
0.04
12.19
Return on Investment (TTM)
vs sector
8.65
14.38
Return on Equity (TTM)
vs sector
8.97
16.08

EXECUTIVE LEADERSHIP

Osamu Nagayama
Chairman of the Board, Representative Director, Since 2018
Salary: --
Bonus: --
Tatsuro Kosaka
President, Chief Executive Officer, Representative Director, Since 2018
Salary: --
Bonus: --
Motoo Ueno
Vice Chairman of the Board, Representative Director, Since 2012
Salary: --
Bonus: --
Toshiaki Itagaki
Chief Financial Officer, Senior Executive Officer, Director of Finance & Accounting, Senior Manager of IT, Senior Manager of Finance, Since 2017
Salary: --
Bonus: --
Junichi Ebihara
Senior Executive Officer, Director of Legal Affairs, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

15F, Nihonbashi Mitsui Tower
2-1-1, Nihonbashi-Muro-machi
CHUO-KU   TKY   103-8324

Phone: +813.32816611

CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Domestic segment is engaged in the sale of pharmaceutical products manufactured by the Company through its nationwide appointed stores. This segment is also involved in the research, development, transportation and storage of pharmaceutical products, as well as the provision of literature research services for pharmaceutical information. The Overseas segment is engaged in the sale of its pharmaceutical products in oversea markets, such as Germany, the United Kingdom, France, Taiwan, China Mainland, Korea and the United States. This segment is also involved in the provision of pharmaceutical academic information, as well as the research, development and registration of pharmaceutical products.

SPONSORED STORIES